temporal

El Marco de Comunicación GUIDE ofrece un sencillo enfoque de 5 pasos para optimizar el papel de la enfermera en el fortalecimiento de la toma de decisiones compartidas entre los pacientes con cáncer colorrectal y su equipo sanitario. Los mismos principios pueden aplicarse de forma más amplia a las interacciones con pacientes con cualquier otro tipo de cáncer. Realiza ahora el aprendizaje electrónico acreditado. Para acceder al curso tendrás que iniciar sesión o abrir una cuenta en COR2ED Checkpoint.

Fransen McGinley is a certified physicians assistant in the Gastrointestinal Cancers Clinic at the Stephenson Cancer Center, Oklahoma City. After completing her bachelor’s degree in Microbiology at the University of Oklahoma, she earned her master’s degree from the University of Oklahoma Health Sciences Physician Associate Program. Fransen has more than 12 years of experience as an oncology PA at the University of Oklahoma Health Sciences Center. She is an active member of the National Commission on Certification of Physician Assistants, as well as of the Oklahoma Academy of Physician Assistants.

Sven De Keersmaecker works as a Study Coordinator at the Antwerp University Hospital since 2015, caring for study patients and outpatients. Sven is a graduate nurse since 1997 and worked initially in Intensive Care before moving to work in Oncology in Antwerp in 2000. Over the years, he acted as a nurse navigator in digestive oncology and was involved in the development of coaching programs for patient and health informatics tools to help them with compliance and monitoring of side effects.

Nina Grenon is a nurse practitioner caring for patients with Gastrointestinal Cancers for the past 22 years, 14 at the Dana-Farber Cancer Institute and the previous 8 years at the Massachusetts General Hospital Cancer Center. She is adjunct faculty at Simmons College, School of Nursing and Health Sciences and serves as a clinical preceptor for nurse practitioner students at Yale University, Simmons College and MGH Institute of Health Professions. She serves on the North America Neuroendocrine Association Tumor Society, regional education committee. Nina Grenon is a frequent national and regional lecturer in colon and pancreatic cancer, published a number of articles in the nursing implication in the management of side effects in patients treated for colon cancer. She is currently on the Oncology Nursing Society Congress Planning Team for 2020. Her research and quality improvement interest include patient and care taker education, specific intervention delivered by front line nurses and the early integrating of palliative care in patients with advanced gastrointestinal malignancies specifically pancreatic cancer.

The GUIDE Communication Framework: shared decision-making tool

Episode

2

of

episodes
GI NURSES CONNECT
Experts
Fransen McGinley, Nina Grenon, Sven De Keersmaecker
Endorsed By
Fight Colorectal Cancer Digestive Cancers Europe
  • download Downloadable
    Resouces
  • clock 60 MIN
  • calendar Sep 2021
  • EACCME
This educational programme is supported by an Independent Medical Education Grant from Bayer
Programme summary
Take the e-learning now
Share this programme
This educational programme is supported by an Independent Medical Education Grant from Bayer
Accreditation
EACCME
This course has been accredited by EACCME® for 1 ECMEC®.
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GI NURSES CONNECT

GI NURSES CONNECT is an initiative of COR2ED, supported by Independent Educational Medical Grants from Bayer and Eisai Europe Limited.

Meet the experts

Other programmes of interest

GI-oncology-GI-CONNECT-10-years-thumbnail-GI2403 Video
Oncology 
Celebrating the 10th anniversary of GI CONNECT

10 years of independent medical education in GI oncology

Experts
Assoc. Prof. Gerald Prager, Assoc. Prof. Joleen Hubbard, Dr Thomas Winder, Prof. Andrea Sartore-Bianchi, Dr Dominik Modest
  • clock 2 MIN
  • calendar Apr 2024

Educational programme supported by an Independent Medical Education grant from Bayer.
Breast-Cancer-Connect-ER-HER2-low-thumbnail-BR2310 Tweetorial
Oncology 
Tweetorial video: Treating ER+/HER2-low metastatic breast cancer, 2L and beyond

Journey through a patient case from testing and diagnosis to treatment and AE management

Experts
Dr Aditya Bardia
Endorsed by
GRASP
  • clock 11 MIN
  • calendar Apr 2024

Educational programme supported by an Independent Medical Education grant from Menarini Stemline Oncology.
NSCLC-perseverance-pays-off- thumbnail-PO2305 Podcast
Oncology 
Perseverance in molecular testing in NSCLC pays off

Looking beyond the obvious mutations in non-small-cell lung cancer

Experts
Prof. Frédérique Penault-Llorca, Prof. Mark Socinski
  • download Downloadable
    Resources
  • clock 26 MIN
  • calendar Mar 2024

Educational programme supported by an Independent Medical Education grant from Bayer
Conference update
Oncology 
ER+ advanced breast cancer: Highlights from EBCC-14 satellite symposium

Medical experts discuss current and upcoming treatment strategies to use after CDK4/6 inhibitors in patients with ER+/HER2- advanced breast cancer

Experts
Prof. Valentina Guarneri, Prof. Matteo Lambertini, Prof. Federico Rojo
  • download Downloadable
    Resources
  • clock 6 MIN
  • calendar Mar 2024

Educational programme supported by an Independent Medical Education grant from Menarini Stemline.
Podcast
Oncology 
mCRC: Optimising patient outcomes with late-line treatment

Maximising outcomes for patients with advanced CRC

Experts
Assoc. Prof. Gerald Prager, Dr Victor Hugo Fonseca de Jesus
Endorsed by
Digestive Cancers Europe 5th anniversary
  • download Downloadable
    Resources
  • clock 23 MIN
  • calendar Mar 2024

Educational programme supported by an Independent Medical Education grant from Bayer.
Interactive patient case
Oncology 
TRK fusion-positive lung cancer: Diagnosis and treatment

Make decisions for your patient at two key stages in their journey

Experts
Prof. Fernando López-Ríos, Prof. Mark Socinski
  • clock 60 MIN
  • calendar Mar 2024

Educational programme supported by an Independent Medical Education grant from Bayer